Valuation: ResMed, Inc.

Market Cap 30.24B 26.48B 24.39B 22.64B 42.99B 2,884B 43.57B 292B 114B 1,416B 114B 111B 4,909B P/E 2026 *
19.8x
P/E 2027 * 17.9x
Enterprise Value 29.38B 25.73B 23.7B 22B 41.77B 2,802B 42.34B 284B 110B 1,376B 110B 108B 4,769B EV / Sales 2026 *
5.2x
EV / Sales 2027 * 4.7x
Free-Float
75.61%
Yield 2026 *
1.16%
Yield 2027 * 1.28%
1 day+5.66%
1 week+11.36%
Current month+13.39%
1 month+14.41%
3 months-1.76%
6 months-11.32%
Current year-8.26%
1 week 192.8
Extreme 192.805
221.21
1 month 184.65
Extreme 184.65
221.21
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
06-08Fiscal year

Chief Executive Officer

14,973 0.0103%
06-01Tax

General Counsel

-269 0.0002%
05-07Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+5.65%+11.36%-13.82%+2.78% 30.24B
-1.18%+1.85%+23.19%-0.30% 195B
+3.02%+8.09%-17.94%+32.91% 151B
-1.97%+0.54%-2.91%-17.31% 140B
-0.51%+3.40%-56.70%-14.98% 67.09B
+1.19%+4.61%+24.37%+5.44% 54.34B
-0.26%+2.41%-25.15%-29.38% 44.63B
-0.52%+2.21%+8.74%+42.28% 37.24B
+0.32%-1.39%+9.84%+10.61% 36.91B
-0.51%+0.11%-12.72%-17.69% 29.82B
Average +0.60%+2.56%-6.31%+1.44% 78.58B
Weighted average by Cap. +0.19%+3.34%-2.94%+2.53%

Financials

2026 *2027 *
Net sales 5.65B 4.95B 4.56B 4.23B 8.03B 539B 8.14B 54.56B 21.23B 265B 21.22B 20.75B 917B 6.09B 5.34B 4.92B 4.56B 8.66B 581B 8.78B 58.84B 22.9B 285B 22.89B 22.38B 989B
Net income 1.55B 1.36B 1.25B 1.16B 2.2B 148B 2.23B 14.95B 5.82B 72.47B 5.81B 5.68B 251B 1.7B 1.49B 1.37B 1.27B 2.41B 162B 2.44B 16.38B 6.37B 79.42B 6.37B 6.23B 275B
Net Debt -859M -752M -693M -643M -1.22B -81.95B -1.24B -8.3B -3.23B -40.23B -3.23B -3.16B -139B -1.57B -1.38B -1.27B -1.18B -2.24B -150B -2.27B -15.18B -5.91B -73.62B -5.9B -5.77B -255B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
06/07/26 $220.70 +5.28% 2,486,265
02/07/26 $209.63 +4.24% 1,144,252
01/07/26 $201.10 +3.19% 1,111,986
30/06/26 $194.88 -1.79% 1,503,607
29/06/26 $198.43 -0.93% 1,396,294
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
209.63USD
Average target price
260.60USD
Spread / Average Target
+24.31%

Quarterly revenue - Rate of surprise